Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the growth hormone deficiency market right now?

In recent years, the market size for growth hormone deficiency has experienced substantial growth. It is projected to increase from $4.06 billion in 2024 to $4.31 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.1%. The historical growth can be credited to several factors, such as the surge in strategic initiatives, increasing brain tumor incidences, escalating demand for hormone treatments, a growing elderly demographic, and increased government healthcare funding.

How fast Is the growth hormone deficiency market expected to grow, and what’s its future value?

The market size for growth hormone deficiency is projected to witness substantial expansion in the coming years. It is estimated to reach $5.42 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this growth during the forecast period include the increasing incidences of genetic disorders, a rise in strategic initiatives, enhanced research and development, greater morbidity because of growth hormone disease, and an increase in clinical trials. The forecast period is predicted to see trends like technological progression, the introduction of a wider range of treatments, advances in diagnostic methods, groundbreaking recent developments, and progress in the field of biotechnology.

Get your growth hormone deficiency market report here!

https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report

What are the leading drivers of growth in the growth hormone deficiency market?

The escalating occurrence of genetic anomalies is poised to boost the development of the growth hormone deficiency market in the future. Genetic anomalies pertain to health conditions that are prompted by irregularities or mutations in a person’s DNA, which can be inherited or arise spontaneously. The escalating occurrence of these anomalies points to improvements in diagnostic technology, heightened awareness, increased maternal age, environmental influences leading to mutations, population expansion, and enhanced survival rates for those affected. Growth hormone deficiency aids in addressing growth-related issues in some genetic conditions. For example, a report released by the Department of Health & Social Care (DHSC), a UK-based government body, in December 2022 revealed that about 33,000 entire genome equivalents were sequenced in October 2022, boasting an average diagnostic yield of 32%, which increased to 61% in specific instances. Therefore, the escalating occurrence of genetic disorders propels the development of the growth hormone deficiency market.

What are the key segments defining the growth hormone deficiency market?

The growth hormone deficiency market covered in this report is segmented –

1) By Type: Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency

2) By Treatment: Pharmacological Therapy, Recombinant Human Growth Hormone, Human Pituitary Gland Extracts, Surgery

3) By Route Of Administration: Intravenous, Intramuscular, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Pediatric Growth Hormone Deficiency: Idiopathic Growth Hormone Deficiency, Genetic Growth Hormone Deficiency, Acquired Growth Hormone Deficiency

2) By Adult Growth Hormone Deficiency: Primary Growth Hormone Deficiency, Secondary Growth Hormone Deficiency

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21197&type=smp

Who are the key players steering the development of the growth hormone deficiency market?

Major companies operating in the growth hormone deficiency market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Eli Lilly and Company, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Genentech Inc., Ipsen Biopharmaceuticals Inc., Opko Health Inc., JCR Pharmaceuticals Co. Ltd., Ferring Pharmaceuticals Inc., Ascendis Pharma A/S, Rani Therapeutics Inc., AnkeBio Co. Ltd., Aeterna Zentaris Inc., Zhongshan Sinobioway Hygene Biomedicine Co. Ltd., Versartis Inc., I-Mab Biopharma Co. Ltd.

What are the key trends shaping the future of the growth hormone deficiency market?

Leading enterprises within the growth hormone deficiency market are concentrating on the creation of cutting-edge products, like unmodified somatropin, which are utilized for daily pediatric growth hormone deficiency (GHD) remedies. Unmodified somatropin is the familiar growth hormone applied in day-to-day pediatric growth hormone deficiency treatments, however, it is being dispensed in a weekly dose with Skytrofa. In September 2023, Ascendis Pharma A/S, a biopharmaceutical firm based in Denmark, introduced SKYTROFA (lonapegsomatropin) for the weekly therapy of pediatric growth hormone deficiency (GHD). This revolutionary treatment provides superior convenience, boosted adherence, and possibly superior treatment results compared to conventional day-to-day growth hormone therapies. It’s the inaugural and sole FDA-endorsed weekly therapy for pediatric GHD, putting it at the forefront of advancements in endocrinology and pediatric healthcare.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21197

Which regions are most influential in expanding the growth hormone deficiency market?

North America was the largest region in the growth hormone deficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the growth hormone deficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cholesterol Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Antibody Contract Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report

Global Market Report 2025

https://thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: